Nanorods Provide Golden Opportunity to Detect Cancer | GenomeWeb

In the future, the value of gold might be measured in nanometers instead of in carats — especially for people with breast cancer. Joseph Irudayaraj’s lab at Purdue University is taking advantage of the optical and physical properties of gold to develop nanorods that can be used as diagnostic tools. Once in blood, these rods circulate and attach to specific cells. Right now, Irudayaraj is working on getting the gold nanorods to adhere to different types of breast cancer cells.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.